Table 2.
Precautions to Consider | Rationale |
---|---|
Dedicated rooms (e.g., in COVID-19–free zones) for immunosuppressed patients | To avoid using potentially contaminated equipment in immunocompromised patients |
Use of “off-site” scanning locations | For cancer centers that do not have their own echocardiography laboratories, consider using an off-site location where the concentration of COVID-19 exposure may be less or moving a dedicated ultrasound machine to the cancer center |
“Low exposure risk” sonographers to scan patients | Having sonographers un-exposed to COVID-19–positive patients and low risk of being asymptomatic carriers (e.g., no travel in past 14 days) may reduce potential risk of transmission |
Using point-of-care ultrasound whenever possible with capacity to store images | Equipment easier to clean and assessment of LVEF assessment, masses, and pericardial effusions are the priority and can be assessed with these devices |
Avoid ECG leads | ECG cables are challenging to clean between patients and may become a source of transmission |
Use ultrasound transducer sleeves and single-use ultrasound gel packets | Use of disposable protective probe sleeves and gel can minimize transmission |
Perform focused studies | Because the primary question in these patients is left ventricular function, short protocols to assess left ventricular function with focus on two-dimensional imaging may be sufficient |
Use PPE as per hospital guidelines and specific barriers developed at the institution to protect sonographers and patients | Consider all patients to be asymptomatic carriers and take appropriate precautions. Consider requesting patients to wear masks/gloves if PPE available |
Perform analysis after patient encounter | All post-processing should be done outside the clinical room setting to minimize exposure to patient |
Reconsider low-yield tests | Sonographers and imaging laboratories should actively assess requests for screening tests in cancer survivors and consider in consultation with oncologist/cardio-oncologist if these tests could be safely postponed |
Use of imaging-enhancing agents in nondiagnostic echo studies only | Limit use of an imaging enhancement agent to nondiagnostic echocardiogram studies to minimize examination length |
Consider alternative imaging modalities (e.g., MUGA) | Alternate imaging modalities (e.g., MUGA scans) which can be performed rapidly while minimizing patient/ technologist exposure (https://zenodo.org/record/3738020#.XoXsHIhKiUk) |
ECG = electrocardiography; MUGAs = multigated acquisition scans; PPE = personal protective equipment; other abbreviations as in Table 1.